Two Sigma Advisers
ANIX icon

Two Sigma Advisers’s Anixa Biosciences ANIX Stock Holding History

Two Sigma Advisers’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-14,438
Closed -$40K – 2641
2022
Q1 		$40K Sell
14,438
-37,400
-72% -$110K ﹤0.01% 2612
2021
Q4 		$154K Sell
51,838
-4,700
-8% -$19K ﹤0.01% 2349
2021
Q3 		$270K Sell
56,538
-5,100
-8% -$23K ﹤0.01% 2154
2021
Q2 		$239K Buy
61,638
+47,938
+350% +$204K ﹤0.01% 2217
2021
Q1 		$64K Buy
13,700
+3,600
+36% +$17.2K ﹤0.01% 2482
2020
Q4 		$31K Sell
10,100
-26,222
-72% -$65.9K ﹤0.01% 2339
2020
Q3 		$88K Buy
+36,322
New +$93.7K ﹤0.01% 2281

Other funds holding ANIX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Advisers's ANIX Position: Q2 2022 in Review

Two Sigma Advisers sold out of Anixa Biosciences (ANIX) in Q2 2022, closing a stake of 14,438 shares — an estimated $40K sold.

Two Sigma Advisers first reported a position in ANIX in Q3 2020 and held it in 7 quarters. The position peaked at $270K in Q3 2021. 45 funds tracked by Wall St. Rank hold ANIX as of Q2 2022.

  • Two Sigma Advisers reported no remaining Anixa Biosciences position as of Q2 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 14,438 Anixa Biosciences shares in Q2 2022, an estimated $40K.
  • Two Sigma Advisers first reported a position in Anixa Biosciences in Q3 2020 and held it in 7 quarters.
  • Two Sigma Advisers's Anixa Biosciences position peaked at $270K in Q3 2021.
  • 45 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2022.

Based on Two Sigma Advisers's 13F filing for Q2 2022, filed 15 Aug 2022.